On January 12-15, Sprint Bioscience will be present at J.P. Morgan Healthcare Week, the most important meeting place of the year for the global life science industry. Leading players gather here for a week filled with partnering, investor meetings and groundbreaking ideas. For Sprint Bioscience, this is a unique opportunity to present preclinical drug programs and make strategic contacts. In an interview...

In an interview with BioStock, CEO Johan Emilsson reports an increased interest in early drug programs. The agreement made in 2025 regarding one of programs has served as a strong seal of approval, not only validating the company's technology platform but also opening doors to new contacts and increasing interest in the entire portfolio.

Watch the interview with Johan Emilsson here:
Sprint Bioscience participates at J.P. Morgan Healthcare Week in San Francisco

Follow our journey and stay updated on our progress - subscribe to our press releases:
SE: Subscribe - Sprint Bioscience
EN: Subscribe - Sprint Bioscience